FDA NDC Directory · JSON-LD · Markdown

Hydroxyzine Pamoate

NDC 50268-398 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAvPAK
Marketing categoryAbbreviated NDA (generic) · App ANDA040156
Dosage form / routeCAPSULE · ORAL
Active ingredientsHYDROXYZINE PAMOATE (25 mg/1)
Marketing started20210414
Package count1

External sources

Source: openFDA. Public-domain (CC0).